Technology | August 27, 2014

Faster Hemostasis, Shorter Hold Times With StatSeal Advanced Disc

Product is ideal product following diagnostic and interventional procedures

Hemostasis Biolife StatSeal Advanced Disc Cath Lab

August 27, 2014 — Cath Labs, interventional radiology suites and hospitals are continually trying to improve patient comfort as well as save time and reduce costs. With these goals in mind, Biolife introduces StatSeal Advanced Disc.

Using the same U.S. Food and Drug Administration (FDA)-cleared formulation of potassium ferrate and hydrophilic polymer found in StatSeal Advanced Powder, StatSeal Advanced Disc creates an instant seal for faster hemostasis and shorter hold times following diagnostic and interventional procedures. The Advanced Disc is easy to use for sheath and catheter removals and is much more cost-effective than hemostasis pads or patches.

“Labs require technology that provide the clinical benefits to meet patient needs. However, most technologies are time consuming and expensive for hospital staff and aggravating to the patient,” stated Tifton Fordham, RN, Biolife. “With StatSeal Advanced Disc, staff can now treat their patients with a product that produces faster hemostasis, ambulation times and patient throughput compared with current technologies.

“At the same time, the clinic is more productive by seeing more patients, increasing staff efficiency and decreasing costs from products that don’t work as well as StatSeal,” Fordhan said.

For more information: www.biolife.com

Related Content

Baylis Medical and Siemens Co-Sponsor Transseptal Access Training Course
News | EP Lab| October 18, 2017
Baylis Medical Co. Inc. and Siemens Healthineers are co-sponsoring a first-of-its kind training program aimed at...
Societies Issue New Performance and Quality Measures for Treating Patients with Heart Attack
News | Cath Lab| October 17, 2017
The American College of Cardiology and the American Heart Association recently released updated clinical performance...
First Patient Enrolled in U.S. Arm of ALIVE Pivotal Heart Failure Trial
News | Heart Failure| October 17, 2017
October 17, 2017 — BioVentrix Inc. recently announced enrollment of the first patient in the U.S.
Dee Dee Wang runs Henry Ford Hospital's 3D printing lab for its complex structural heart cardiology program.

Dee Dee Wang, M.D., runs Henry Ford Hospital's 3-D printing lab that supports its complex structural heart program.

Feature | 3-D Printing| October 13, 2017 | Dave Fornell
Three-dimensional (3-D) printed anatomic models created from a patient’s computed tomography (CT), magnetic resonance...
Videos | Chronic Total Occlusion (CTO)| October 09, 2017
Bill Lombardi, M.D., director of complex coronary artery interventions at the University of Washington, discusses the
BTG Acquires Roxwood Medical
News | Business| October 05, 2017
BTG plc announced it has acquired Roxwood Medical, provider of advanced cardiovascular specialty catheters used in the...
TVA Medical Receives CE Mark for Next-Generation EverlinQ 4 EndoAVF System
News | Vascular Access| October 04, 2017
TVA Medical Inc. announced that its everlinQ 4 endoAVF System has received CE Mark in the European Union. The...
Reflow Medical's Wingman Crossing Catheter Receives FDA Clearance for Coronary Indication
News | Catheters| October 02, 2017
October 2, 2017 — Reflow Medical Inc. announced that the company has received 510(k) clearance from the U.S.
TherOx Gains FDA PMA Approval for SSO2 Therapy System
Technology | Cath Lab| September 29, 2017
September 29, 2017 — TherOx Inc. announced that the U.S.
Avinger Receives CE Mark for In-Stent Restenosis Indication With Pantheris Image-Guided Atherectomy
Technology | Atherectomy Devices| September 29, 2017
Avinger Inc. recently announced Conformité Européenne (CE) Marking approval for treating in-stent restenosis with the...
Overlay Init